RxDoctor Payments Data

John Lake, MD

Gastroenterology · Minneapolis, MNNPI 1740360619

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,525 of the $10,704 with a category attached, or 89.0%.

$10,704in general payments, 2019–2025

Across 13 payments — averaging $823.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$6K
  • Mallinckrodt Hospital Products Inc.$5K
$215,550in research payments, 2019–2025

Across 56 payments — averaging $3849.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mallinckrodt Enterprises LLC$111K
  • Intercept Pharmaceuticals, Inc.$104K

What the payments were for

  • Consulting fees$9,52589%
  • Travel & lodging$9529%
  • Food & beverage$2282%

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.12$5,699
Mallinckrodt Hospital Products Inc.1$5,005

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,704 in reported general payments places this provider in the 80th percentile of 365 gastroenterology providers in Minnesota.

See all gastroenterology providers in Minnesota

Medicare billing

Part B allowed, 2024
$32,630
Medicare patients
210
Services billed
283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin61$237,275
Everolimus36$85,075
Ursodiol337$53,801
Tacrolimus321$43,071
Sirolimus44$34,480
Mycophenolate Mofetil193$17,334
PrografTacrolimus13$16,713
Cyclosporine ModifiedCyclosporine, Modified94$15,411
Entecavir40$9,704
Tenofovir Disoproxil Fumarate86$9,155
Mycophenolic AcidMycophenolate Sodium32$7,233
Lactulose56$6,524
Azathioprine60$2,675
Prednisone195$2,070
Fludrocortisone Acetate55$1,529

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →